Lots of lipstick

Lots of lipstick

Ok we know people are getting tired, more like sick and tired, of hearing it but it does bear repeating the conventional glucose monitoring market is headed down the tubes and there is not much anyone can do about it. Now this won’t happen overnight but it’s fair to say this market which once was more than $6 billion globally will shrink to just $1 billion globally within 5 years or sooner. Reimbursement continues to decline while at the same time becoming less prevalent. Prices continue to decline as payors look for even greater savings. Thanks to CGM . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.